Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00665600 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)
A Phase 3 study, sponsored by Sumitomo Pharma America.
- Completed
- Registry status
- Phase 3
- Development phase
- 257
- Enrollment target
NCT00665600 is a Phase 3 study that has completed, run by Sumitomo Pharma America. The registered enrollment target is 257 participants.
The verdict
NCT00665600, a Phase 3 study, has completed, sponsored by Sumitomo Pharma America.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 257 participants
- Enrollment target
Study Summary
To investigate the efficacy and safety of repeated dosing of Levalbuterol over 6 weeks of treatment in COPD.
Interventions
- DRUG Placebo
- DRUG Albuterol Sulfate
- DRUG Levalbuterol HCl
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2002-02 |
| Est. Completion | 2003-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00665600
The ClinicalTrials.gov registry entry for NCT00665600 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sumitomo Pharma America, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00665600 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00665600 about?
NCT00665600 is a clinical study titled "Efficacy and Safety of Levalbuterol in Chronic Obstructive Pulmonary Disease (COPD)". To investigate the efficacy and safety of repeated dosing of Levalbuterol over 6 weeks of treatment in COPD.
What is the current status of trial NCT00665600?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 257 participants. The study started on 2002-02. Estimated completion is 2003-03.
What interventions are being tested in trial NCT00665600?
The interventions under investigation include: Placebo (DRUG), Albuterol Sulfate (DRUG), Levalbuterol HCl (DRUG).
Who is sponsoring clinical trial NCT00665600?
This trial is sponsored by Sumitomo Pharma America, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.